Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.
This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...
Unprecedented surge in Irish exports this year was almost entirely driven by shipments of drug ingredients for Eli Lilly ...
Workplace stress, long hours, and unhealthy habits are raising diabetes risk among India’s young professionals. Awareness and ...
MedPage Today on MSN
Ozempic Weight Loss Ads; New Dietary Guidelines; More Type 1.5 Diabetes Diagnoses
New analyses of an investigational high-dose semaglutide pill for obesity showed improvements in blood sugar control and ...
While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...
Novo Nordisk A/S remains attractive with strong cash flow and robust pipeline. Click here to read why NVO stock is a Buy.
The Hearty Soul on MSN
An Apple a Day? 5 Benefits of Apples From Gut Health to Weight Loss
An apple a day keeps the doctor away, or so the old proverb says. But, is there any truth to it? Apples are both affordable ...
Modern Family Driver on MSN
Ozempic’s Shocking Impact on Obesity Rates Is Finally Here
GLP-1 drugs like Ozempic are reshaping obesity care, blending real weight loss gains with new questions about safety, access, ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Colleen Dawkins, FNP-C, RD, CSOWM ...
Novo Nordisk maintains strong growth prospects, driven by obesity treatment market expansion. See why NVO stock is a strong ...
Human brains are wired to hold on to fat, resist calorie restriction, and push themselves towards foods that keep them alive, even if they make them gain weight in modern life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback